Additional studies, particularly of GLP-1 RA, GIP and GLP-1 RA, and SGLT2i, will hopefully provide new avenues to reduce mortality in this population, in which there are enormous health disparities
And you'll leave with a plan that feels like it came from a real understanding not a checkbox
For patients who are responders to these medications, we would recommend that [they] should stay on these indefinitely, Dr
When all 56,004 participants from all 7 trials were analyzed together, primary and secondary endpoints of death from cardiovascular causes (fatal or nonfatal stroke, fatal or nonfatal MI) remained significant, albeit modest
L-carnitine is able to be synthesized in the hepatic and renal systems of humans and dogs, this is not possible within the cardiac or skeletal muscle and thus L-carnitine is either absorbed from the diet or biosynthesized by other tissues (Verney et al
Another phase 2 trial using a higher dose of mazdutide for obesity (9 mg) is currently ongoing with a press release revealing a placebo-adjusted WL of 15.4% after 24 weeks [71]